The FDA recently approved a new device from Medtronic that turns a smartphone into a patient’s pacemaker monitor that can send stats to their doctor in real time. The MyCareLink Smart Monitor is able ...
On February 20, 2024, Medtronic MDT Corporation (NYSE: MDT, $85.90, Market Capitalization: $114.2 billion) in its 3Q24 earnings call announced that it no longer plans to spin-off its Patient ...
Medical leaders Medtronic and Abbott are collaborating on diabetes care in a new partnership that will combine technologies to expand options for patients. Medtronic is known for insulin pumps with ...
Medtronic Inc. said Monday that a continuous glucose monitoring system recently received European regulatory approval. The Fridley-based medical technology giant said the Sentrino system -- the first ...
Abbott Laboratories is linking its continuous glucose monitoring with automated insulin delivery by entering a global partnership with health tech giant Medtronic. The pairing of Abbott's leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback